Cargando…
Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?
The search for new diagnostic tests for cancer or ways to improve existing tests is primarily driven by the desire to identify the disease as early as possible. In this report, we summarize the current knowledge of the most promising diagnostic protein bladder cancer (BC) markers reported over the l...
Autores principales: | Shlyapnikov, Yuri M., Malakhova, Ekaterina A., Vinarov, Andrey Z., Zamyatnin, Andrey A., Shlyapnikova, Elena A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917292/ https://www.ncbi.nlm.nih.gov/pubmed/33659273 http://dx.doi.org/10.3389/fmolb.2020.620687 |
Ejemplares similares
-
Multiple Diversity of Mitochondrial Cytochrome b Amino Acid Sequences of the Same Length in Animals
por: Zamyatnin, Alexander A., et al.
Publicado: (2020) -
Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients
por: Tang, Xingxing, et al.
Publicado: (2020) -
Editorial: Exosomal biomarkers: Roles in diagnostics and therapeutics
por: Gupta, Dwijendra K.
Publicado: (2023) -
Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney Cancer
por: Gudkov, Alexander, et al.
Publicado: (2022) -
Gene-centric coverage of the human liver transcriptome: QPCR, Illumina, and Oxford Nanopore RNA-Seq
por: Ilgisonis, Ekaterina V., et al.
Publicado: (2022)